Skip to main content
HLB PHARMACEUTICAL CO., LTD. logo

HLB PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 047920 ISIN · KR7047920004 KO Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2025-05-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 047920

About HLB PHARMACEUTICAL CO., LTD.

https://www.hlbpharma.co.kr/eng/

HLB PHARMACEUTICAL CO., LTD. is a biopharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company specializes in the production of quasi-drugs, such as alcohol swabs for disinfecting wounds and sterilizing medical devices. Its portfolio also includes prescription medications like skeletal muscle relaxants. A key focus of its research and development activities is the discovery and advancement of new peptide-based drugs. As part of the broader HLB Group, it contributes to a diverse portfolio that spans pharmaceuticals, medical devices, and diagnostics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Life Science) in a listed company (HLB Pharmaceutical). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2025-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is a standard regulatory disclosure for major shareholders (in this case, HLB Life Science reporting on its stake in HLB Pharmaceutical) to report changes in their shareholding position. This falls under the category of Major Shareholding Notification (MRQ).
2025-05-29 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Pharmaceutical Co., Ltd. covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial data, business operations, management discussions, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase) by HLB Pharmaceutical. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2025-05-08 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). This type of regulatory filing in the Korean market is a standard disclosure for material corporate events, specifically M&A activity or significant asset acquisitions. Since it details the acquisition of shares, the transaction terms, and the rationale, it falls under the M&A Activity category.
2025-04-24 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission and the Korea Exchange. It specifically details a 'Decision on Paid-in Capital Increase' (유상증자결정), which involves the issuance of new shares via third-party allocation. This falls under the category of capital structure changes and financing activities, which is classified as 'CAP' (Capital/Financing Update).
2025-04-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.